SHERIDAN, Wyo., Nov. 20, 2026 /PRNewswire/ -- The global digital diabetes management market is valued at USD 20.9 billion in 2026 and is projected to reach USD 34.4 billion by 2031, growing at a CAGR of 10.5% over the forecast period (2026-2031), according to a new study by Wissen Research.

Diabetes care is moving out of the clinic and onto the wrist, the arm and the smartphone. Continuous glucose monitors (CGM), automated insulin delivery (AID) systems, smart insulin pens and cloud platforms now feed data to patients and care teams in near real time. The International Diabetes Federation estimates that 589 million adults were living with diabetes in 2024, a figure projected to reach 853 million by 2050, which gives the sector a large and growing patient base. Companies are competing less on single devices and more on whose sensors, pumps and software work best together.
Get a Free Sample of This Report to Explore Key Findings and Data: https://www.wissenresearch.com/request-a-sample/?report=global-digital-diabetes-management-market
Care Is Shifting From the Clinic to the Home
Glooko's 2025 Global Diabetes Report found that remote diabetes data uploads overtook in-clinic uploads in early 2024, and by the end of that year remote uploads were about 1.5 times higher. The analysis tracked device synchronization across North America and EMEA between June 2020 and June 2025. For healthcare providers, connected platforms mean glucose patterns and time-in-range can be reviewed between appointments, so treatment can be adjusted without waiting for the next visit.
Type 2 Diabetes Is the Next Big Growth Pool
CGM and AID were built around Type 1 diabetes, but manufacturers are now extending them to broader groups. In August 2024, the U.S. FDA expanded the indication for Insulet's SmartAdjust technology to adults with Type 2 diabetes. A 2025 randomized trial of 72 adults with Type 2 diabetes not taking insulin found that CGM users raised time-in-range from 46% to 72% over six months, with a 1.3-percentage-point reduction in HbA1c. Results from small trials need confirming in larger studies, but they help explain why companies are targeting this population.
Over-the-counter products are widening access further:
What's Fueling Growth in the Digital Diabetes Management Market
Challenges Facing the Digital Diabetes Management Market
Cost is the biggest barrier. Sensors, pumps and consumables carry recurring costs, and in the U.S., Medicare CGM coverage remains tied to insulin treatment or documented problematic hypoglycemia. A 2025 study across six low- and middle-income countries found sensor prices of roughly USD 88 to 107 each, and a month's supply required about 15 to 65 days of wages. Other hurdles include interoperability between manufacturers, data privacy and cybersecurity, patchy connectivity and limited digital health literacy.
Recent Strategic Developments in the Digital Diabetes Management Market
In November 2026, Tandem Diabetes Care, Inc. of the United States received multiple Health Canada approvals for its t:slim X2 insulin pump with Control-IQ+ technology. The approvals cover compatibility with Abbott's FreeStyle Libre 3 Plus sensor and expanded indications for adults with Type 2 diabetes and for people with Type 1 diabetes during pregnancy. Commercial availability is expected in the second quarter of 2027.
In October 2026, DexCom, Inc. of the United States announced the Canadian launch of its Dexcom G7 15 Day system, which offers up to 15.5 days of sensor wear and an overall mean absolute relative difference (MARD) of 8.0%. Public reimbursement for eligible people with Type 1 and Type 2 diabetes begins in November 2026, alongside coverage through participating private plans.
In October 2026, Insulet Corporation of the United States announced the full U.S. release of Omnipod Discover, a web-based data management platform for Omnipod 5 users, caregivers and healthcare professionals. During its limited release, the platform was adopted by more than 15,000 Omnipod 5 users and 1,800 healthcare professionals.
In August 2026, Abbott Laboratories of the United States announced a multi-year partnership with Google Health to combine glucose insights from its Lingo over-the-counter CGM with Google's AI-powered health technology. The collaboration includes a large research study to improve AI-based health coaching using glucose, nutrition, activity, sleep and stress data.
Where the Competition Is Heating Up
Key Insights from Digital Diabetes Management Market Analysis
Key Players in the Digital Diabetes Management Market
Leading companies are focusing on CGM, automated insulin delivery, connected insulin pens, cloud-based platforms and AI-enabled glucose analytics, while widening product indications and improving interoperability.
Regional Analysis and Growth Opportunities
North America's leadership reflects established CGM adoption, developed reimbursement infrastructure, strong medical device commercialization and the presence of the major manufacturers.
Asia Pacific is the fastest-growing region. According to the IDF Diabetes Atlas 2025, the Western Pacific region had about 215.4 million adults with diabetes in 2024, and South-East Asia had another 106.9 million. The South-East Asia figure is projected to rise 73% to 184.5 million by 2050. China, India, Indonesia and Japan offer substantial opportunity for CGM makers, connected insulin delivery providers and digital health platforms. More broadly, the IDF reports that 81% of adults with diabetes live in low- and middle-income countries, which points to demand for affordable sensors, smartphone-based monitoring and localized platforms. Europe, Latin America and the Middle East & Africa complete the report's regional coverage.
Get a Custom Briefing on This Market for Your Business
Wissen Research's analysts are available to walk through findings specific to your market, region, or competitive set.
Need Insights Specific to Your Business? Request a Customized Version of This Report: https://www.wissenresearch.com/request-customization/?report=global-digital-diabetes-management-market
Market Segmentation Snapshot
The global digital diabetes management market is segmented by product and service, device type, end user and region:
Frequently Asked Questions
Q: What is the size of the digital diabetes management market? A: The global digital diabetes management market is estimated at USD 20.9 billion in 2026 and is projected to reach USD 34.4 billion by 2031.
Q: What is the growth rate of the digital diabetes management market? A: The market is projected to grow at a CAGR of 10.5% between 2026 and 2031.
Q: What is driving the market? A: Key drivers include wider CGM adoption, expansion of automated insulin delivery, growth in remote monitoring, improving reimbursement and the extension of connected devices to Type 2 diabetes.
Q: Which product and service segment leads the market? A: Devices held the leading position in 2025.
Q: Which device type leads the market? A: Wearable devices held the leading position by device type in 2025.
Q: Which region leads the digital diabetes management market? A: North America held the leading position in 2025, while Asia Pacific is the fastest-growing region.
Q: Who are the top players in the digital diabetes management market? A: Leading companies include Abbott Laboratories, DexCom, Inc., Medtronic plc, Insulet Corporation and Tandem Diabetes Care, Inc.
Q: How consolidated is the market? A: It is moderately fragmented across device manufacturing, software platforms and connected services, with stronger positions in categories such as CGM and automated insulin delivery.
With sensors, pumps and software increasingly designed to work together, the winners are likely to be companies that combine accurate devices, dependable connectivity and affordable access, particularly as connected diabetes care expands beyond Type 1 and into emerging markets.
Get the Complete Digital Diabetes Management Market Report: Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/global-digital-diabetes-management-market
Expert Profile | Mayur Jain, Wissen Research
Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry.
Email: mayur@wissenresearch.com
LinkedIn: https://www.linkedin.com/in/mayur-jain-0190542a/
About Wissen Research
Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets
Company Contact:
Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research
View original content to download multimedia:https://www.prnewswire.com/news-releases/digital-diabetes-management-market-to-reach-us-34-4-bn-by-2031--growing-at-10-5-cagr-wissen-research-302947258.html
SOURCE Wissen Research LLC